Stay updated on Pembrolizumab CNS Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.

Latest updates to the Pembrolizumab CNS Metastases Clinical Trial page
- Check5 days agoChange DetectedResults Submitted appears, replacing No Results Posted. The page revision has been updated to v3.4.3 from v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAddition: Revision: v3.4.2. Deletions: removal of a government funding lapse notice and related operating-status updates (Revision: v3.4.1).SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about the lapse in government funding and NIH Clinical Center operating status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedChanges consist of minor UI/text updates, including showing the glossary, capitalization tweaks, and a version note, which do not alter the study content or key information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 is now displayed on the page, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedLocations section updated to include Massachusetts as a study location and the page revision updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab CNS Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.